Preclinical Study of Single-Dose Moxidectin, a New Oral Treatment for Scabies: Efficacy, Safety, and Pharmacokinetics Compared to Two-Dose Ivermectin in a Porcine Model

BACKGROUND: Scabies is one of the commonest dermatological conditions globally; however it is a largely underexplored and truly neglected infectious disease. Foremost, improvement in the management of this public health burden is imperative. Current treatments with topical agents and/or oral ivermec...

Descripción completa

Detalles Bibliográficos
Autores principales: Bernigaud, Charlotte, Fang, Fang, Fischer, Katja, Lespine, Anne, Aho, Ludwig Serge, Dreau, Dominique, Kelly, Andrew, Sutra, Jean-François, Moreau, Francis, Lilin, Thomas, Botterel, Françoise, Guillot, Jacques, Chosidow, Olivier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5061321/
https://www.ncbi.nlm.nih.gov/pubmed/27732588
http://dx.doi.org/10.1371/journal.pntd.0005030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5061321/
https://www.ncbi.nlm.nih.gov/pubmed/27732588
http://dx.doi.org/10.1371/journal.pntd.0005030

Ejemplares similares